CS201544B2 - Process for preparing derivatives of piperazine - Google Patents

Process for preparing derivatives of piperazine Download PDF

Info

Publication number
CS201544B2
CS201544B2 CS77726A CS72677A CS201544B2 CS 201544 B2 CS201544 B2 CS 201544B2 CS 77726 A CS77726 A CS 77726A CS 72677 A CS72677 A CS 72677A CS 201544 B2 CS201544 B2 CS 201544B2
Authority
CS
Czechoslovakia
Prior art keywords
methyl
methanol
piperazine
hydrogen
diphenylmethyl
Prior art date
Application number
CS77726A
Other languages
Czech (cs)
English (en)
Inventor
Richard Cyrus
Manfred Raschack
Original Assignee
Knell Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knell Ag filed Critical Knell Ag
Publication of CS201544B2 publication Critical patent/CS201544B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
CS77726A 1976-02-07 1977-02-03 Process for preparing derivatives of piperazine CS201544B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
CS201544B2 true CS201544B2 (en) 1980-11-28

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
CS77726A CS201544B2 (en) 1976-02-07 1977-02-03 Process for preparing derivatives of piperazine

Country Status (25)

Country Link
US (1) US4079137A (sv)
JP (1) JPS52105186A (sv)
AT (1) AT355578B (sv)
AU (1) AU504526B2 (sv)
BE (1) BE850492A (sv)
CA (1) CA1094560A (sv)
CH (1) CH631448A5 (sv)
CS (1) CS201544B2 (sv)
DD (1) DD128133A5 (sv)
DE (1) DE2604845A1 (sv)
DK (1) DK138891C (sv)
ES (1) ES455691A1 (sv)
FI (1) FI63226C (sv)
FR (1) FR2340311A1 (sv)
GB (1) GB1550545A (sv)
HU (1) HU173483B (sv)
IE (1) IE44339B1 (sv)
IL (1) IL51316A (sv)
LU (1) LU76706A1 (sv)
NL (1) NL7700841A (sv)
NO (1) NO142625C (sv)
PL (1) PL105526B1 (sv)
PT (1) PT66154B (sv)
SE (1) SE7701187L (sv)
ZA (1) ZA77248B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
AU2005314271B2 (en) 2004-12-06 2011-06-16 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as cancer vaccine adjuvants
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
EP2240195A4 (en) * 2007-12-12 2011-12-21 Sciclone Pharmaceuticals Inc TREATMENT OF MELANOMA WITH ALPHA-THYMOSIN PEPTIDES IN ASSOCIATION WITH ANTIBODIES AGAINST ANTIGEN 4 ASSOCIATED WITH CYTOTOXIC LYMPHOCYTE T (CTLA4)
CA2708229A1 (en) * 2007-12-13 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor
EP2230908A1 (en) * 2007-12-14 2010-09-29 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
WO2010129947A2 (en) * 2009-05-08 2010-11-11 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
CN113855806A (zh) 2014-10-21 2021-12-31 赛生药品股份国际有限公司 用免疫刺激剂治疗癌症

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate

Also Published As

Publication number Publication date
CH631448A5 (de) 1982-08-13
DK138891C (da) 1979-04-23
DK138891B (da) 1978-11-13
IL51316A0 (en) 1977-03-31
DK49077A (da) 1977-08-08
DE2604845A1 (de) 1977-08-18
PL105526B1 (pl) 1979-10-31
BE850492A (fr) 1977-07-18
AU2195277A (en) 1978-08-10
IE44339B1 (en) 1981-10-21
PT66154B (fr) 1978-07-07
SE7701187L (sv) 1977-08-08
FI770398A (sv) 1977-08-08
ES455691A1 (es) 1978-01-01
NO142625B (no) 1980-06-09
LU76706A1 (sv) 1977-06-28
IE44339L (en) 1977-08-07
FR2340311B1 (sv) 1980-02-08
AU504526B2 (en) 1979-10-18
GB1550545A (en) 1979-08-15
HU173483B (hu) 1979-05-28
JPS52105186A (en) 1977-09-03
US4079137A (en) 1978-03-14
FI63226B (fi) 1983-01-31
CA1094560A (en) 1981-01-27
NO770374L (no) 1977-08-09
ZA77248B (en) 1977-11-30
FR2340311A1 (fr) 1977-09-02
DD128133A5 (de) 1977-11-02
PT66154A (fr) 1977-03-01
ATA68177A (de) 1979-08-15
IL51316A (en) 1980-12-31
AT355578B (de) 1980-03-10
NL7700841A (nl) 1977-08-09
NO142625C (no) 1980-09-17
FI63226C (fi) 1983-05-10

Similar Documents

Publication Publication Date Title
US3188313A (en) 1-[(1-, 2- and 3-indolyl)-lower]piperazine derivatives and intermediates and processes for the preparation thereof
US3686206A (en) Pyrazole and pyrazolone aminoketones
CA1143727A (en) Triazole derivatives
US5686612A (en) Methods of making ureas and guanidines, including terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin, and bunazosin (exemplary of 2-substituted quinazoline compounds), and meobentine, and bethanidine and intermediates thereof
DK157861B (da) Analogifremgangsmaade til fremstilling af 4-substituerede fenylalkylimidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf
CS201544B2 (en) Process for preparing derivatives of piperazine
US3974158A (en) 2-(Substituted anilino)methylmorpholines
CA2781858C (en) Modulators of tnf-.alpha. signaling
US5852019A (en) Pyrimidinylpyrazole derivatives
US4945096A (en) Treatment of a depressive state with 2-[(4-piperidyl)methyl]-1,2,3,4-tetrahydroisoquinoline derivates
US5095022A (en) Piperidine derivatives and pharmaceutical compositions comprising the same
JPH1067753A (ja) 新規ベンゾイミダゾール、ベンゾオキサゾール及びベンゾチアゾール化合物、その製造方法、並びにそれを含有する医薬組成物
US4868175A (en) 4-Benzyl-1-(2H)-phthalazineone derivatives having an amino acid radical
EP0579059B1 (en) Pyridazinone derivatives and processes for preparing the same
JPH05262761A (ja) アリールアルキルアミン誘導体
US5401743A (en) Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof
US3859305A (en) Indole aminoketones
US5418235A (en) Aminoalkyl-substituted 5-mercaptothiazoles, the preparation and use thereof
JPS60208948A (ja) ３−フエニル−２−プロペンアミン誘導体、その製法およびそれを含有する組成物
CA1171085A (en) Cyclopropylmethyl piperazines, the process for preparing the same and their use in therapeutics
WO1991011444A1 (fr) Compose de piperazine, sa production et son utilisation en medecine
RU2001914C1 (ru) Способ получени 4-[3-(4-оксотиазолидинил)-бутинил]-амина и его фармацевтически приемлемых кислотно-аддитивных солей
US4029786A (en) Morpholine derivatives for treating depression
CS249503B2 (en) Method of new 1-(3-/3,4,5-trimethoxyphenoxy/-2-hydroxypropyl-4-aryl-piperazine derivatives production
CS210699B2 (en) Method of preparation of substituted aminoalkylguanidines